The A2 Milk Company Ltd (A2M.AX): FY27 a transition year, with full recovery expected by FY28

研报英文原文证据摘录

Vi ewp oint |

17 Aug 2026 17:25:00 ET │ 20 pages

The A2 Milk Company Ltd (A2M.AX)

FY27 a transition year, with full recovery expected by FY28

CITI'S TAKE

a2’s track record of strong execution warrants backing the management

team to regain market share lost from recent supply chain disruptions faster

than expected, and as such, we upgraded our rating to Buy (from Neutral).

However, this recovery will take time (as the guidance assumes) and

investors are likely to show patience if a2 demonstrates ongoing

improvements in offtake and other metrics. The next catalyst will be the

AGM.

Share will take time to return, as we flagged, but some green shoots — There is

still uncertainty around the pace of China label market share recovery. a2 is guiding

to flat revenue growth in 1H, which suggests patience is needed. The July 26 retail

sales offtake is 40% (of the CY25 monthly average), which is reasonable considering

the magnitude of the 4Q26 out of stock position, and there are positive leading

indicators such as: i) Social media sentiment tracking in July 2026, and from mid

August 2026, an intensive new user education and recruitment campaign is

planned, followed by a larger brand campaign in October 2026, and ii) new user

recruitment efforts (e.g., mother-baby classes) are showing positive results with

conversion rates back to or exceeding historical levels. Strategically, following the

supply issues, a2 has restricted distribution to 2/3 of the original offline network,

which is likely to lead to the retailers with allocations being able to generate

improved sales productivity, which in turn should keep them motivated to support

the brand, with anecdotes of a2 receiving increased shelf space.

n

Buy

Price (17 Aug 26 16:00)

A$6.53

Target price

A$7.40

Expected share price return

13.3%

Expected dividend yield

2.8%

Expected total return

16.1%

Market Cap

A$4,737M

US$3,356M

Price Performance

(RIC: A2M.AX, BB: A2M AU)

Innovation driving growth — The business is becoming less dependent on a single

China label IMF growth vector than in prior years, with innovation driving >50% of

FY26 sales growth. This should continue with a number of new product launches

…